• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 11 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Jose Espinosa, Argentina

      Jose Espinosa, Argentina

    • Mikey Stone, ALS

      Mikey Stone, ALS

    • Shaleen Latchman, Canada

      Shaleen Latchman, Canada

    • Bjarne Hytjanstorp, Norway

      Bjarne Hytjanstorp, Norway

    • Marco Antonio Alvarez Mercado, Mexico

      Marco Antonio Alvarez Mercado, Mexico

    • Andrietta, Italy

      Andrietta, Italy
      Andrietta

    • Lucy Lintott, Scotland

      Lucy Lintott, Scotland

    • Fabio Correia, Brazil

      Fabio Correia, Brazil

    • Greg Heydet, USA

      Greg Heydet, USA

    • Elkin Gaviria, Colombia

      Elkin Gaviria, Colombia

    • Malu Araujo Ribeiro, Brazil

      Malu Araujo Ribeiro, Brazil

    • Tso-Ta Huang, Taiwan

      Tso-Ta Huang, Taiwan

    • Sam Hayden-Harler, UK

      Sam Hayden-Harler, UK

    • Orly Dichoso, Canada

      Orly Dichoso, Canada

    • Liong Ting Ngu, Malaysia

      Liong Ting Ngu, Malaysia

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • Shay Rishoni, Netherlands

      Shay Rishoni, Netherlands

    • Danny Reviers, Belgium

      Danny Reviers, Belgium
      DannyReviers

    • Gudjon Sigurdsson, Iceland

      Gudjon Sigurdsson, Iceland

    • João Marcos Andrietta, Brazil

      João Marcos Andrietta, Brazil

    • Ada Garrido Benavidez, Mexico

      Ada Garrido Benavidez, Mexico

    • Claudia Gotti, Brazil

      Claudia Gotti, Brazil

    • Erwin Coppejans, Belgium

      Erwin Coppejans, Belgium

    • Mona H. Bahus and Camilla Knoff Glomstad, Norway

      Mona H. Bahus and Camilla Knoff Glomstad, Norway

    • Elisabeth Zahnd, Switzerland

      Elisabeth Zahnd, Switzerland

    • Steve Gallagher, Canada

      Steve Gallagher, Canada
      Picture1

    • Jorge Melo, Brazil

      Jorge Melo, Brazil

    • Jay Epstein, USA

      Jay Epstein, USA

    • Jean

      Jean
      jean

    • Mike Rannie, Canada

      Mike Rannie, Canada

    • Yolanda Armendariz, Mexico

      Yolanda Armendariz, Mexico

    • Peng Yi-Wen, Taiwan

      Peng Yi-Wen, Taiwan

    • Malcolm Buck, Australia

      Malcolm Buck, Australia

    • Emilienne Verhaegen, Belgium

      Emilienne Verhaegen, Belgium

    • David Solomon, UK

      David Solomon, UK

    • Wiebke Braach, Germany

      Wiebke Braach, Germany

    • Willi Klein, UK

      Willi Klein, UK

    • John Sweeney, USA

      John Sweeney, USA

    • Catherine Pearce, Australia

      Catherine Pearce, Australia

    • Paul Launer, USA

      Paul Launer, USA

    • Fabrice Kamp, Germany

      Fabrice Kamp, Germany

    • Maria Santos Garcia Tellez, Mexico

      Maria Santos Garcia Tellez, Mexico

    • Carlos Alberto Báez Murillo, Colombia

      Carlos Alberto Báez Murillo, Colombia

    • Alberto Baez Murillo, Colombia

      Alberto Baez Murillo, Colombia

    • Aida Trzmiel de Guterman, Argentina

      Aida Trzmiel de Guterman, Argentina

    • Calum Ferguson, Scotland

      Calum Ferguson, Scotland

    • Jon Newsome, USA

      Jon Newsome, USA

    • Joyce Rusinak, USA

      Joyce Rusinak, USA

    • Art Eggert, USA

      Art Eggert, USA

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login